Literature DB >> 17031678

A novel deletion in the GJA12 gene causes Pelizaeus-Merzbacher-like disease.

Leonardo Salviati1, Eva Trevisson, Maria Cristina Baldoin, Irene Toldo, Stefano Sartori, Milena Calderone, Romano Tenconi, AnnaMaria Laverda.   

Abstract

Pelizaeus-Merzbacher disease (PMD) and Pelizaeus-Merzbacher-like disease (PMLD) are hypomyelinating disorders of the central nervous system with a very similar phenotype. PMD is an X-linked disorder caused by mutations in PLP1. PMLD is an autosomal recessive condition caused by mutations in GJA12. We report a 5-year-old girl with a complex neurological syndrome and severe hypomyelination on brain magnetic resonance imaging. She harbored a homozygous 34-bp deletion in the coding region of GJA12. There are no distinctive features for the differential diagnosis of PMD/PMLD. GJA12 should be analyzed in all patients without PLP1 mutations but should also be considered the initial genetic test in women and in patients with consanguineous parents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17031678     DOI: 10.1007/s10048-006-0065-x

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  10 in total

1.  Nomenclature for the description of human sequence variations.

Authors:  J T den Dunnen; S E Antonarakis
Journal:  Hum Genet       Date:  2001-07       Impact factor: 4.132

2.  Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Clinical European Network on Brain Dysmyelinating Disease.

Authors:  F Cailloux; F Gauthier-Barichard; C Mimault; V Isabelle; V Courtois; G Giraud; B Dastugue; O Boespflug-Tanguy
Journal:  Eur J Hum Genet       Date:  2000-11       Impact factor: 4.246

3.  Frameshift mutations and the genetic code. This paper is dedicated to Professor Theodosius Dobzhansky on the occasion of his 66th birthday.

Authors:  G Streisinger; Y Okada; J Emrich; J Newton; A Tsugita; E Terzaghi; M Inouye
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1966

4.  GJA12 mutations in children with recessive hypomyelinating leukoencephalopathy.

Authors:  M Bugiani; S Al Shahwan; E Lamantea; A Bizzi; E Bakhsh; I Moroni; M R Balestrini; G Uziel; M Zeviani
Journal:  Neurology       Date:  2006-05-17       Impact factor: 9.910

Review 5.  PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2.

Authors:  Ken Inoue
Journal:  Neurogenetics       Date:  2004-12-31       Impact factor: 2.660

6.  Meta-analysis of gross insertions causing human genetic disease: novel mutational mechanisms and the role of replication slippage.

Authors:  Jian-Min Chen; Nadia Chuzhanova; Peter D Stenson; Claude Férec; David N Cooper
Journal:  Hum Mutat       Date:  2005-02       Impact factor: 4.878

7.  Connexins are critical for normal myelination in the CNS.

Authors:  Daniela M Menichella; Daniel A Goodenough; Erich Sirkowski; Steven S Scherer; David L Paul
Journal:  J Neurosci       Date:  2003-07-02       Impact factor: 6.167

8.  Degree of hypomyelination and magnetic resonance spectroscopy findings in patients with Pelizaeus Merzbacher phenotype.

Authors:  B Plecko; S Stöckler-Ipsiroglu; S Gruber; V Mlynarik; E Moser; J Simbrunner; F Ebner; G Bernert; G Harrer; A Gal; D Prayer
Journal:  Neuropediatrics       Date:  2003-06       Impact factor: 1.947

9.  Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease.

Authors:  Birgit Uhlenberg; Markus Schuelke; Franz Rüschendorf; Nico Ruf; Angela M Kaindl; Marco Henneke; Holger Thiele; Gisela Stoltenburg-Didinger; Fuat Aksu; Haluk Topaloğlu; Peter Nürnberg; Christoph Hübner; Bernhard Weschke; Jutta Gärtner
Journal:  Am J Hum Genet       Date:  2004-06-10       Impact factor: 11.025

10.  Neurophysiological study in Pelizaeus-Merzbacher disease.

Authors:  A Nezu
Journal:  Brain Dev       Date:  1995 May-Jun       Impact factor: 1.961

  10 in total
  13 in total

1.  High frequency of GJA12/GJC2 mutations in Turkish patients with Pelizaeus-Merzbacher disease.

Authors:  B Bilir; Z Yapici; C Yalcinkaya; I Baris; C M B Carvalho; M Bartnik; B Ozes; M Eraksoy; J R Lupski; E Battaloglu
Journal:  Clin Genet       Date:  2012-02-20       Impact factor: 4.438

2.  Pelizaeus-Merzbacher-like disease caused by AIMP1/p43 homozygous mutation.

Authors:  Miora Feinstein; Barak Markus; Iris Noyman; Hannah Shalev; Hagit Flusser; Ilan Shelef; Keren Liani-Leibson; Zamir Shorer; Idan Cohen; Shareef Khateeb; Sara Sivan; Ohad S Birk
Journal:  Am J Hum Genet       Date:  2010-11-18       Impact factor: 11.025

Review 3.  Gap junctions in inherited human disease.

Authors:  Georg Zoidl; Rolf Dermietzel
Journal:  Pflugers Arch       Date:  2010-02-07       Impact factor: 3.657

4.  Pelizaeus-Merzbacher-like disease is caused not only by a loss of connexin47 function but also by a hemichannel dysfunction.

Authors:  Simone Diekmann; Marco Henneke; Birgitta C Burckhardt; Jutta Gärtner
Journal:  Eur J Hum Genet       Date:  2010-05-05       Impact factor: 4.246

Review 5.  Gap junctions in inherited human disorders of the central nervous system.

Authors:  Charles K Abrams; Steven S Scherer
Journal:  Biochim Biophys Acta       Date:  2011-08-16

6.  Gene therapy targeting oligodendrocytes provides therapeutic benefit in a leukodystrophy model.

Authors:  Elena Georgiou; Kyriaki Sidiropoulou; Jan Richter; Christos Papaneophytou; Irene Sargiannidou; Alexia Kagiava; Georg von Jonquieres; Christina Christodoulou; Matthias Klugmann; Kleopas A Kleopa
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

7.  Magnetic resonance imaging pattern recognition in hypomyelinating disorders.

Authors:  Marjan E Steenweg; Adeline Vanderver; Susan Blaser; Alberto Bizzi; Tom J de Koning; Grazia M S Mancini; Wessel N van Wieringen; Frederik Barkhof; Nicole I Wolf; Marjo S van der Knaap
Journal:  Brain       Date:  2010-10       Impact factor: 13.501

8.  Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment.

Authors:  David N Finegold; Catherine J Baty; Kelly Z Knickelbein; Shelley Perschke; Sarah E Noon; Diana Campbell; Jenny M Karlsson; Diana Huang; Mark A Kimak; Elizabeth C Lawrence; Eleanor Feingold; Stephen D Meriney; Adam M Brufsky; Robert E Ferrell
Journal:  Clin Cancer Res       Date:  2012-02-20       Impact factor: 12.531

9.  Hereditary spastic paraplegia is a novel phenotype for GJA12/GJC2 mutations.

Authors:  Jennifer L Orthmann-Murphy; Ettore Salsano; Charles K Abrams; Alberto Bizzi; Graziella Uziel; Mona M Freidin; Eleonora Lamantea; Massimo Zeviani; Steven S Scherer; Davide Pareyson
Journal:  Brain       Date:  2008-12-04       Impact factor: 13.501

10.  GJC2 promoter mutations causing Pelizaeus-Merzbacher-like disease.

Authors:  Leo Gotoh; Ken Inoue; Guy Helman; Sara Mora; Kiran Maski; Janet S Soul; Miriam Bloom; Sarah H Evans; Yu-Ichi Goto; Ljubica Caldovic; Grace M Hobson; Adeline Vanderver
Journal:  Mol Genet Metab       Date:  2013-12-16       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.